DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

SUNDARAM HOME FINANCE LIMITED — Chapter VIII - Specifications related to ISIN for debt

NSE 1 hr ago·1 Oct 2026, 12:07 pm

Sundaram Finance

Sundaram Home Finance has updated its debt securities specifications, specifically related to the International Securities Identification Number (ISIN). This change is a standard administrative update required for regulatory compliance and proper market tracking of the company's debt instruments.

For investors, this update does not alter the financial performance or risk profile of the company. It primarily ensures that the debt securities are correctly identified and reported in the market, which is essential for accurate record-keeping and transparency. Investors should not be concerned about any operational changes to their holdings due to this filing.

Moving forward, it is important to monitor the company's official disclosures for any further updates. This specification change is a routine procedural step, and investors should focus on the broader credit health and business performance of the company rather than this specific regulatory filing.